Jun 302019
 

slider-ehcp2019_0

The European Meeting on Hypertension and Cardiovascular Protection (ESH) is the largest annual research and clinical meeting for interested specialists. This year’s event took place in Milan, Italy on June 21–24 and brought together about 2,500 participants.

At the Congress, Alexandra Konradi, Deputy Director General for Research and Head of Arterial Hypertension Research Department at Almazov Centre gave a presentation on gender-oriented approaches to managing patients with arterial hypertension.

A particular focus of this year's event was patient compliance as an important determinant for successful treatment of hypertension. According to experts, non-compliance can be considered as a stand-alone cardiovascular risk factor along with dyslipidemia, smoking or sedentary lifestyle.

Prof. Maciej Tomaszewski (UK), President of the International Society of Hypertension, spoke about the methods that can reveal non-compliance and Prof. Michel Burnier (Switzerland) highlighted that improving patient compliance is one of the most difficult challenges in treatment.

The Congress featured joint sessions of ESH and specialized societies of other countries. Special focus was given to the treatment of arterial hypertension in patients with chronic kidney disease, including in patients receiving hemodialysis; clinical and scientific value of orthostatic reactions; the importance of non-drug therapy.

The Congress was accompanied by a large exhibition where the participants could learn about new fixed-dose combinations of antihypertensive drugs, innovative techniques of cuffless blood pressure measurement and attend a workshop on analyzing vascular stiffness and interpreting daily monitors.

There were a lot of interesting posters at the poster session. The following specialists of Almazov Centre presented their posters:

  • Korostovtseva, Researcher of Somnology Group, Arterial Hypertension Research Department
  • Bochkarev, Researcher of Somnology Group, Arterial Hypertension Research Department
  • Mironova, Researcher, Research Laboratory for Pathogenesis and Therapy of Arterial Hypertension
  • Ionov, Researcher, Department of Pathogenesis and Treatment of Arterial Hypertension
  • K. Tolkunova, first-year cardiology resident, Epidemiology Research Laboratory headed by O. Rotar

The versatile programme of the Congress allowed the participants the opportunity to learn about modern world trends and innovative developments in the field of arterial hypertension treatment and became the starting point for further scientific and clinical work.